News
(2)April 2026
Nkarta Highlights Clinical Trial Advances in Annual Update
# 📄 Document Overview This is Nkarta, Inc.'s (NKTX) **Annual Report to Shareholders (ARS)**. Think of it as the company's annual "report card" sent directly to its owners (the shareholders). It combines the formal 10-K filing with a more graphical, summarized, and often more visually engaging pres
Nkarta Shareholders to Vote on Director Elections and Compensation
# 🔍 **Nkarta, Inc. (NKTX) Proxy Statement Breakdown** This document is a **Definitive Proxy Statement (DEF 14A)** for Nkarta's 2026 Annual Meeting of Stockholders. It outlines proposals for stockholders to vote on and provides essential company governance, director nominations, and executive compe
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.